Stomach Bug H. pylori Smuggles a Cancer-Linked Protein Into Your Cells’ Nuclei

Helicobacter pylori infects roughly half the world's population and is the leading microbial driver of gastric cancer, responsible for an estimated 850,000 cancer cases globally in 2020 alone. Scientists have long known the bacterium deploys an arsenal of virulence proteins, but the delivery mechanisms behind some of those weapons have remained murky. New investigational research published in the Journal of Extracellular Vesicles now points to a surprisingly direct route: H. pylori loads a nucleomodulin called Tipα into its extracellular vesicles and ships it straight to the nuclei of gastric epithelial cells.

Tipα travels inside bacterial extracellular vesicles, not as free protein

Tipα is a secreted bacterial protein that shares 94.3% sequence homology with HP-MP1, a factor previously linked to TNF induction and tumor formation. The central question this study addressed was how Tipα actually gets from the bacterium into host cells, and whether it travels as free soluble protein or in some packaged form.

The answer, according to the new findings, is clear packaging. Western blotting of culture supernatants showed that the majority of secreted Tipα is associated with extracellular vesicles rather than floating freely. A key experiment confirmed this: when researchers treated purified EVs with proteinase K, an enzyme that degrades surface-exposed proteins, Tipα survived the treatment intact. Heat shock proteins HspA and HspB, along with catalase and urease subunit B, were all digested, indicating they sit on the vesicle surface. Tipα was not, indicating it is encapsulated inside the vesicles. This distinction matters because encapsulated cargo is shielded from immune detection during transit, a significant advantage for a bacterium trying to manipulate host cells without triggering an immediate alarm.

Gastric epithelial cells receive the Tipα payload within four hours

Once released, where do these vesicles go? The research team labeled H. pylori EVs with the fluorescent dye DiO and tracked them in gastric epithelial cell cultures using confocal microscopy. Within four hours of incubation, labeled vesicles were observed close to host cell nuclei. They were not associated with the Golgi apparatus or the endoplasmic reticulum, suggesting a relatively direct trafficking route rather than one involving the standard secretory machinery.

Cell fractionation assays confirmed that EV-associated Tipα localizes to the nuclear compartment. Recombinant Tipα also reached the nucleus independently, though the study found that binding to surface nucleolin, a receptor sometimes implicated in nuclear import, was not required for this trafficking. Flow cytometry across several gastric cancer cell lines showed poor surface nucleolin expression, and co-immunoprecipitation did not confirm direct Tipα-nucleolin binding, leaving the precise import mechanism an open question.

EV entry into host cells was reduced by inhibitors of dynamin-dependent endocytosis and macropinocytosis, suggesting those pathways are involved in vesicle uptake. Prior work has shown that H. pylori-derived EVs are elevated in the gastric juices of adenocarcinoma patients and can induce inflammation in epithelial cells, providing context for why understanding EV trafficking matters clinically. Separately, research into EVs from H. pylori-infected gastric epithelial cells has shown these vesicles can promote malignancy-associated changes in uninfected recipient cells, underscoring that vesicle-mediated signaling is a broader theme in H. pylori pathogenesis.

Tipα appears to dampen inflammatory responses and aid colonization

The functional consequences of EV-delivered Tipα point in a counterintuitive direction: rather than simply inflaming tissue, Tipα may actually suppress host immune responses in ways that help the bacterium persist.

When researchers compared EVs from wild-type H. pylori to EVs from isogenic tipA mutant strains lacking the gene, a striking pattern emerged. Ultracentrifuge-purified EVs from tipA mutants induced significantly greater TNF and IL-8 production in host cells than EVs from wild-type or complemented bacteria. In other words, EVs carrying Tipα provoked less inflammation, not more, at least in this experimental context. The implication is that EV-associated Tipα plays an immunosuppressive role, potentially helping H. pylori avoid clearance during the early stages of colonization.

Mouse colonization studies reinforced this picture. H. pylori SS1 tipA mutant bacteria were unable to colonize mice, while wild-type and complemented strains could. Gastric mucosal TNF levels were lower in Tipα-challenged mice compared to animals infected with wild-type bacteria, though the difference did not reach statistical significance. Recombinant Tipα and EVs from both wild-type and tipA mutant strains also showed DNA-binding activity in electrophoretic mobility shift assays, a property that may relate to Tipα's role as a nucleomodulin once inside the host nucleus.

Isolation method and strain differences complicate the picture

The study surfaces two important technical and biological caveats. First, the method used to isolate EVs significantly influenced the results. Ultracentrifuge-purified EVs from tipA mutants showed clear cytokine differences from wild-type EVs; size exclusion chromatography-purified EVs showed no such differential response between strains. The researchers attribute this partly to differences in the biomolecular corona, the coating of proteins and lipids that adheres to EV surfaces during purification, which is retained differently by each method. This is an underexplored variable in prokaryotic EV research generally, and the finding is a caution flag for interpreting any EV immunology data without knowing how the vesicles were prepared.

Second, Tipα from different H. pylori strains behaves differently. Recombinant Tipα from strain 26695 induced significantly higher TNF production than rTipα from strain SS1, likely due to a 20-amino acid sequence extension and non-synonymous substitutions between strains. The significance of Tipα divergence between East Asian and European H. pylori isolates remains unresolved.

Open questions on Tipα's nuclear role and therapeutic relevance

This research is explicitly investigational. The clinical isolate set was small, preventing any firm conclusions about whether higher Tipα secretion correlates with worse cancer outcomes. Complemented tipA+ bacteria did not fully restore the cytokine-dampening phenotype seen in wild-type strains, suggesting differences in how Tipα gets packaged into EVs that are not yet understood. And while Tipα clearly reaches the nucleus, what it does there, which genes it affects, which epigenetic marks it alters, remains to be worked out.

Those are the questions that will determine whether any of this translates into a therapeutic target. Researchers studying heat shock protein-bearing EVs in H. pylori gastric tumorigenesis have already proposed EV-based biomarkers and therapeutic strategies in the broader H. pylori EV space, and Tipα could eventually slot into that framework. For now, the study establishes the delivery mechanism with reasonable clarity: H. pylori wraps Tipα inside membrane vesicles, ships them to host cell nuclei within hours, and the cargo appears to suppress rather than amplify the immediate inflammatory response. Whether that immune dampening is the key step that allows a short-term infection to become a decades-long cancer risk is the question driving the next phase of research.

Evidence rating

INVESTIGATIONAL — 67/100

Caveats:

• This is preclinical mechanistic research conducted in cell culture models and mice — no human clinical data are presented.
• Causation between EV-delivered Tipα and gastric cancer in humans has not been established.
• Key findings on immunomodulation were dependent on the EV isolation method used, raising reproducibility questions within the study itself.
• The complemented mutant strains did not fully restore wild-type behavior, leaving gaps in the proposed mechanism.
• Funding was not disclosed by the authors.

This is a mechanistic laboratory study combining cell culture, confocal microscopy, mutagenesis, and a mouse colonization model; no human clinical data are presented. Findings establish an association between H. pylori extracellular vesicle-mediated Tipα delivery and altered host immune responses, but the causal chain to human gastric cancer remains undemonstrated. Key immunomodulatory results were dependent on EV isolation methodology, and the study has not been independently replicated.

References

1. Jack K. Emery, Variya Nemidkanam, Nina Colon, et al. (2026). Outer Membrane Vesicles Mediate the Secretion and Nuclear Trafficking of a Bacterial Nucleomodulin. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70286
2. The global epidemiology of gastric cancer and Helicobacter pylori: current and future perspectives for prevention – NCBI. NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360340/
3. Hyun-Il Choi, Jun-Pyo Choi, Jiwon Seo, et al. (2017). Helicobacter pylori-derived extracellular vesicles increased in the gastric juices of gastric adenocarcinoma patients and induced inflammation mainly via specific targeting of gastric epithelial cells. Experimental & Molecular Medicine. https://doi.org/10.1038/emm.2017.47
4. María Fernanda González, Renato Burgos-Ravanal, Baohai Shao, et al. (2022). Extracellular vesicles from gastric epithelial GES-1 cells infected with Helicobacter pylori promote changes in recipient cells associated with malignancy. Frontiers in Oncology. https://doi.org/10.3389/fonc.2022.962920
5. Melania Ionelia Gratie, Olga Maria Manna, Salvatore Accomando, Giovanni Tomasello, Francesco Cappello, Alberto Fucarino (2025). Hsp60-Bearing Exosomes in Helicobacter pylori-Induced Gastric Tumorigenesis: A Pathomorphological and Therapeutical Overview. Cells. https://doi.org/10.3390/cells14211652